Pfizer Vaccine Booster Restores Nearly Full Protection, Company Says
THURSDAY, Oct. 21, 2021 (HealthDay News) — The Pfizer-BioNTech vaccine booster restored close to full protection against COVID-19 in a late-stage trial involving 10,000 people, the company announced Thursday. They said the booster was 95.6% effective and that they plan to submit the latest data to the U.S. Food andContinue Reading